Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 216,890 | 243,574 | 269,907 | 285,053 | 322,399 |
| Receivables | 25,498 | 22,537 | 27,882 | 28,493 | 38,520 |
| Inventories | 40,495 | 45,326 | 46,667 | 49,773 | 50,082 |
| TOTAL | $296,251 | $325,867 | $359,761 | $376,282 | $429,146 |
| Non-Current Assets | |||||
| PPE Net | 151,479 | 158,624 | 162,727 | 166,428 | 164,474 |
| Intangibles | 280,972 | 315,305 | 322,495 | 359,459 | 354,835 |
| Other Non-Current Assets | 41,875 | 49,395 | 51,983 | 57,582 | 59,789 |
| TOTAL | $474,326 | $523,324 | $537,205 | $583,469 | $579,098 |
| Total Assets | $770,577 | $849,191 | $896,966 | $959,751 | $1,008,244 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,440 | 5,440 | 5,440 | 5,440 | 5,440 |
| Accounts payable and accrued liabilities | 2,910 | 7,998 | 11,525 | 9,525 | 11,957 |
| Accrued Expenses | 36,567 | 48,136 | 50,202 | 44,603 | 39,574 |
| TOTAL | $44,917 | $61,574 | $69,682 | $63,158 | $56,971 |
| Non-Current Liabilities | |||||
| Long Term Debt | 286,331 | 287,381 | 288,436 | 289,499 | 290,492 |
| Deferred Revenues | N/A | N/A | 1,639 | 2,756 | N/A |
| Other Non-Current Liabilities | 63,811 | 57,471 | 68,432 | 66,874 | 72,628 |
| TOTAL | $352,949 | $355,758 | $359,301 | $366,320 | $374,064 |
| Total Liabilities | $397,866 | $417,332 | $428,983 | $429,478 | $431,035 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 257,067 | 255,707 | 255,362 | 254,660 | 254,336 |
| Common Shares | 2,560 | 2,554 | 2,553 | 2,547 | 2,527 |
| Retained earnings | 10,118 | 45,799 | 71,355 | 110,946 | 140,891 |
| Other shareholders' equity | 160,856 | 186,995 | 202,698 | 229,983 | 251,917 |
| TOTAL | $372,711 | $431,859 | $467,983 | $530,273 | $577,209 |
| Total Liabilities And Equity | $770,577 | $849,191 | $896,966 | $959,751 | $1,008,244 |